Table 6

Multivariate analysis for survival in breast cancer patients (n = 135 patients)

Markerχ2PSEEXP
n (negative vs. positive)10.9980.00090.7270.090
ER (negative vs. positive)5.5270.01870.6040.513
VEGF/MCP-1a (−/−,+/−,−/+ vs.+/+)4.4170.03560.3382.215
Tumor size (<3 cm vs. ≥3 cm)1.2200.26930.4290.406
  • a VEGF/MCP-1 −/−, VEGF level below median and MCP-1 level under detection level; VEGF/MCP-1 +/−, VEGF level above median and MCP-1 level under detection level; VEGF/MCP-1 −/+, VEGF level below median and MCP-1 detectable level; VEGF/MCP-1 +/+, VEGF level above median and MCP-1 detectable level.